Postencephalitic parkinsonism--a review.
Casals J, Elizan TS, Yahr MD.
J Neural Transm (Vienna). 1998;105(6-7):645-76. doi: 10.1007/s007020050086.
Postencephalitic Parkinsonism: Unique Pathological and Clinical Features-Preliminary Data.
Strobel S, Sian-Hulsmann J, Tappe D, Jellinger K, Riederer P, Monoranu CM.
Cells. 2024 Sep 10;13(18):1511. doi: 10.3390/cells13181511.
Parkinsonism--neuropathology.
Lewis PD.
Br Med J. 1971 Sep 18;3(5776):690-2. doi: 10.1136/bmj.3.5776.690.
Levodopa (L-Dopa).
Gandhi KR, Saadabadi A.
2023 Apr 17. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.
Benztropine.
Ahuja A, Patel P, Abdijadid S.
2024 Jan 29. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.
Postencephalitic parkinsonism: interesting clinico-imaging correlation.
Das B, Chakravarthi S, Goyal MK, Modi M, Vyas S, Lal V, Prabhakar S, Ahuja C.
J Neurol Sci. 2014 Aug 15;343(1-2):215-7. doi: 10.1016/j.jns.2014.05.062. Epub 2014 Jun 5.
Viral parkinsonism.
Jang H, Boltz DA, Webster RG, Smeyne RJ.
Biochim Biophys Acta. 2009 Jul;1792(7):714-21. doi: 10.1016/j.bbadis.2008.08.001. Epub 2008 Aug 12.
[Postencephalitic parkinsonism].
Mori H.
Ryoikibetsu Shokogun Shirizu. 1999;(27 Pt 2):32-5.
L-dopa in postencephalitic parkinsonism.
Calne DB, Stern GM, Laurence DR, Sharkey J, Armitage P.
Lancet. 1969 Apr 12;1(7598):744-6. doi: 10.1016/s0140-6736(69)91751-6.
Symptomatic Parkinsonism.
Pearce J.
Postgrad Med J. 1977 Dec;53(626):726-8. doi: 10.1136/pgmj.53.626.726.
